Evidence map›Paper›PMID 41859173›Full record

ArticleFrontiers in medicine2026

Clinical characteristics and prognostic factors of

Weixiang Lin, Juan Feng, Zhihong Fang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Weixiang LinKey Laboratory of Xiamen for Diagnosis and Treatment of Hematologic Malignancy, Department of Hematology, The First Affiliated Hospital of Xiamen University, Xiamen Hematology Medical Quality Control Center, Xiamen, China.
Juan FengKey Laboratory of Xiamen for Diagnosis and Treatment of Hematologic Malignancy, Department of Hematology, The First Affiliated Hospital of Xiamen University, Xiamen Hematology Medical Quality Control Center, Xiamen, China.
Zhihong FangKey Laboratory of Xiamen for Diagnosis and Treatment of Hematologic Malignancy, Department of Hematology, The First Affiliated Hospital of Xiamen University, Xiamen Hematology Medical Quality Control Center, Xiamen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clostridium perfringens (CP), an anaerobic Gram-positive bacterium, is commonly associated with food poisoning and gas gangrene. In rare instances, it can cause fatal massive intravascular hemolysis (MIH), a condition associated with exceedingly high mortality that poses a serious clinical challenge. A retrospective analysis was performed using a fatal case of T-lymphoblastic lymphoma/leukemia complicated by CP-associated acute hemolysis treated at our center in November 2024 and case reports of CP-associated MIH in hematologic patients from January 1987 to September 2025. A total of 23 eligible cases from our institution and published literature were included. The cohort consisted of 60.8% (

Indexed as

altered mental statusClostridium perfringenshematologic malignanciesintravascular hemolysisprognosis

Identifiers

PMID41859173
PMCPMC12995667

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.